Mutations of telomerase complex genes linked to bone marrow failures

Journal of Nippon Medical School

Volumn 74, Issue 3, 2007, Pages 202-209

  Yamaguchi, Hiroki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Bone marrow failure; Dyskeratosis congenita; Mutation; Telomerase complex gene; Telomere

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE;

APLASTIC ANEMIA; BONE MARROW DEPRESSION; CLINICAL FEATURE; GENE MUTATION; HUMAN; MYELODYSPLASTIC SYNDROME; REVIEW;

CELL CYCLE PROTEINS; DYSKERATOSIS CONGENITA; HUMANS; MUTATION; NUCLEAR PROTEINS; RNA; TELOMERASE;

EID: 34347343718     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.202     Document Type: Review

References (35)

1. Dokal I: Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-779.
2. Marrone A, Walne A, Dokal I: Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev 2005; 15: 249-257.
3. Heiss NS, Knight SW, Vulliamy TJ, et al.: X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38.
4. Vulliamy T, Marrone A, Goldman F, et al.: The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435.
5. Vulliamy TJ, Walne A, Baskaradas A, et al.: Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis 2005; 34: 257-263.
6. Armanios M, Chen JL, Chang YP, et al.: Haploin-sufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A 2005; 102: 15960-15964.
7. Vulliamy TJ, Marrone A, Knight SW, et al.: Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685.
8. Cong YS, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66: 407-425.
9. Vulliamy TJ, Knight SW, Mason PJ, et al.: Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27: 353-357.
10. Vulliamy TJ, Marrone A, Knight SW, et al.: Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685.
11. Marrone A, Dokal I: Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med 2004; 6: 1-23.
12. Fogarty PF, Yamaguchi H, Wiestner A, et al.: Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 2003; 362: 1628-1630.
13. Ball SE, Gibson FM, Rizzo S, et al.: Progressive telomere shortening in aplastic anemia. Blood 1998; 91: 3582-3592.
14. Brummendorf TH, Maciejewski JP, Mak J, et al.: Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001; 97: 895-900.
15. Lee JJ, Kook H, Chung IJ, et al.: Telomere length changes in patients with aplastic anaemia. Br J Haematol 2001; 112: 1025-1030.
16. Filipowicz W, Pogacic V: Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol 2002; 14: 319-327.
17. Salowsky R, Heiss NS, Benner A, et al.: Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity. Gene 2002; 293: 9-19.
18. He J, Navarrete S, Jasinski M, et al.: Targeted disruption of Dkcl, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 2002; 21: 7740-7744.
19. Cheong C, Hong KU, Lee HW: Mouse models for telomere and telomerase biology. Exp Mol Med 2003; 35: 141-153.
20. Ruggero D, Grisendi S. Piazza F, et al.: Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003; 299: 259-262.
21. Mochizuki Y, He J, Kulkarni S, et al.: Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci USA 2004; 101: 10756-10761.
22. Yamaguchi H, Calado RT, Ly H, et al.: Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 2005; 352: 1413-1424.
23. Chen JL, Greider CW: Telomerase RNA structure and function: implications for dyskeratosis congenita. Trends Biochem Sci 2004; 29: 183-192.
24. Vulliamy T, Marrone A, Szydlo R, et al.: Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 2004; 36: 447-449.
25. Vulliamy T, Marrone A, Dokal I, et al.: Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002; 359: 2168-2170.
26. Yamaguchi H, Baerlocher GM, Lansdorp PM, et al.: Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003; 102: 916-918.
27. Takeuchi J, Hinh L, Adam B, et al.: Identification and Functional Characterization of Telomerase RNA Variant Alleles in Japanese Patients with Aplastic Anemia or Myelodysplastic Syndrome. Blood 2006; 108: 292a #977.
28. Keith WN, Vulliamy T, Zhao J, et al.: A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord 2004; 4: 3.
29. Hathcock KS, Hemann MT, Opperman KK, et al.: Haploinsufficiency of mTR results in defects in telomere elongation. Proc Natl Acad Sci USA 2002; 99: 3591-3596.
30. Marrone A, Stevens D, Vulliamy T, et al.: Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood 2004; 104: 3936-3942.
31. Ly H, Calado RT, Allard P, et al.: Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood 2005; 105: 2332-2339.
32. Xin ZT, Beauchamp AD, Calado RT, et al.: Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 2007; 109: 524-532.
33. Liang J, Yagasaki H, Kamachi Y, et al.: Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. Haematologica 2006; 91: 656-658.
34. Liu Y, Snow BE, Hande MP, et al.: The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 2000; 10: 1459-1462. [Erratum, Curr Biol 2001; 11: 907.].
35. Zhang A, Zheng C, Hou M, et al.: Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. Am J Hum Genet 2003; 72: 940-948.